Information about adverse drug reactions reported in children: A qualitative review of empirical studies

British Journal of Clinical Pharmacology

Volumn 70, Issue 4, 2010, Pages 481-491

  Aagaard, Lise ^a   Christensen, Arne ^a   Hansen, Ebba Holme ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

adverse drug reactions; children; incidence; prevalence; spontaneous reporting systems

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; ANTIPARASITIC AGENT; BLOOD DERIVATIVE; CARDIOVASCULAR AGENT; CENTRAL NERVOUS SYSTEM AGENTS; DERMATOLOGICAL AGENT; HORMONE DERIVATIVE; IMMUNOMODULATING AGENT; PSYCHOTROPIC AGENT; VACCINE;

ADOLESCENT; BLOOD DISEASE; CHILD; DRUG EXPOSURE; DRUG MONITORING; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; EMBASE; EMPIRICISM; GASTROINTESTINAL SYMPTOM; HEART DISEASE; HEPATOBILIARY DISEASE; HOSPITALIZED CHILD; HUMAN; INCIDENCE; INFECTION; INFESTATION; INJECTION SITE REACTION; LYMPHATIC SYSTEM DISEASE; MEDLINE; MENTAL DISEASE; METABOLIC DISORDER; NEUROLOGIC DISEASE; NEWBORN; NUTRITIONAL DISORDER; OUTPATIENT; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; QUALITATIVE RESEARCH; REVIEW; SCHOOL CHILD; SKIN DISEASE; SYSTEMATIC REVIEW;

ADOLESCENT; ADVERSE DRUG REACTION REPORTING SYSTEMS; AGE FACTORS; CHILD; CHILD, PRESCHOOL; DENMARK; DRUG TOXICITY; EMPIRICAL RESEARCH; FEMALE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; SEX FACTORS;

EID: 77954558910     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2010.03682.x     Document Type: Review

References (50)

1. Miller MR, Zhan C. Pediatric patient safety in hospitals: a national picture in 2000. Pediatrics 2004 113:1741 1746.
2. Kongkaew C, Noyce PR, Ascroft DM. Hospital admissions associated with adverse drug reactions: a systematic review of prospective observational studies. Ann Pharmacother 2008 42:1017 1025.
3. Sammons HM, Choonara I. Clinical trials of medication in children, 1996-2002. Eur J Clin Pharmacol 2005 61:165 167.
4. Conroy S, McIntyre J, Choonara I, Stephenson T. Drug trials in children: problems and the way forward. Br J Clin Pharmacol 2000 49:93 7.
5. FDA Modernization Act of 1997. Available at http://www.fda.gov/ RegulatoryInformation/Legislation/FederalFoodDrugandCosmeticActFDCAct/ SignificantAmendmentstotheFDCAct/FDAMA/FullTextofFDAMAlaw/default.htm (last accessed 5 May 2010).
6. Regulation EC No. 1901/2006 of the European Parliament and of the Council of 12 December 2006 on medicinal products for paediatric use and amending regulation. Available at http://ec.europa.eu/index-en.htm (last accessed 7 October 2009).
7. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998 15:1200 1205.
8. Einarson TR. Drug-related hospital admissions. Ann Pharmacother 1993 27:832 840.
9. Impicciatore P, Choonara I, Provasi D, Pandolfini C, Bonati M. Incidence of adverse drug reactions in paediatric in/out-patients: a systematic review and meta-analysis of prospective studies. Br J Clin Pharmacol 2001 52:77 83.
10. Strom BL. Pharmacoepidemiology. West Sussex:John Wiley & Sons Ltd, 2005.
11. MedDRA. Available at http://www.meddramsso.com (last accessed 5 May 2010).
12. WHO Collaboration Centre for Drug Statistics Methodology. 2007. Available at http://www.whocc.no/atc-ddd-index/ (last accessed 3 April 2010).
13. Volume 9. Pharmacovigilance: Medicinal products for human use and veterinary products. Available at http://ec.europa.eu/enterprise/ pharmaceuticals/eudralex/homev9.htm (last accessed 3 April 2010).
14. McKenzie MW, Stewart RB, Weiss CF, Cluff LE. A pharmacist-based study of the epidemiology of adverse drug reactions in pediatric medicine patients. Am J Hosp Pharm 1973 30:898 903.
15. Whyte J, Greenan E. Drug usage and adverse drug reactions in paediatric patients. Acta Paediatr Scand 1977 66:767 775.
16. Mitchell AA, Goldman P, Shapiro S, Sloane D. Drug utilization and reported adverse reactions in hospitalized children. Am J Epidemiol 1979 110:196 204.
17. Choonara IA, Harris F. Adverse drug reactions in medical inpatients. Arch Dis Child 1984 59:578 580.
18. Gill AM, Leach HJ, Hughes J, Barker C, Nunn AJ, Choonara IA. Adverse drug reactions in a paediatric intensive care unit. Acta Paediatr 1995 84:438 441.
19. Gonzalez-Martin G, Caroca CM, Paris E. Adverse drug reactions in hospitalised pediatric patients. A prospective study. Int J Clin Pharmacol Ther 1998 36:530 533.
20. Martinez-Mir I, Garcia-Lopez M, Palop V, Ferrer JM, Rubio E, Morales-Olivas FJ. A prospective study of adverse drug reactions in hospitalized children. Br J Clin Pharmacol 1999 47:681 688.
21. Turner S, Nunn AJ, Fielding K, Choonara I. Adverse drug reactions to unlicensed and off-label drugs on paediatric wards: a prospective study. Acta Paediatr 1999 88:965 968.
22. Buajordet I, Wesenberg F, Brørs O, Langslet A. Adverse drug events in children during hospitalization and after discharge in a Norwegian University Hospital. Acta Paediatr 2002 9:88 94.
23. Temple ME, Robinson RF, Miller JC, Hayes JR, Nahata MC. Frequency and preventability of adverse drug reactions in paediatric patients. Drug Saf 2004 27:819 829.
24. Haffner S, von Laue N, Wirth S, Thürmann PA. Detecting adverse drug reactions on pediatric wards. Intensified surveillance versus computerised screening of laboratory values. Drug Saf 2005 28:453 464.
25. Le J, Nguyen T, Law AV, Hodding J. Adverse drug reactions among children over a 10-year period. Pediatrics 2006 118:555 562.
26. Planchamp F, Nguyen K-A, Vial T, Nasri S, Javouhey E, Gillet Y, Ranchin B, Villard F, Floret D, Cochat P, Gueyffier F, Kassai B. Active drug monitoring of adverse drug reactions in pediatric emergency department. Arch Pediatr 2009 16:106 111 (in French).
27. McKenzie MW, Marchall GL, Netzloff ML, Cluff LE. Adverse drug reactions leading to hospitalization in children. J Pediatr 1976 89:487 491.
28. Yosselson-Superstine S, Weiss T. Drug-related hospitalization in paediatric patients. J Clin Hosp Pharm 1982 7:195 203.
29. Mitchell AA, Lacouture PG, Sheehan JE, Kaufmann RE, Shapiro S. Adverse drug reactions in children leading to hospital admission. Pediatrics 1988 82:24 9.
30. Martinez-Mir I, Lopez-Garcia M, Palop V, Ferrer JM, Estan L, Rubio E, Morales-Olivas FJ. A prospective study of adverse drug reactions as a cause of admission to a paediatric hospital. Br J Clin Pharmacol 1996 42:319 324.
31. Easton KL, Parsons BJ, Starr M, Brien JE. The incidence of drug-related problems as a cause of hospital admissions in children. Med J Aust 1998 169:356 359.
32. Kramer MS, Hutchinson TA, Flegel KM, Naimark L, Contardi R, Leduc DG. Adverse drug reactions in general pediatric outpatients. J Pediatr 1985 106:305 310.
33. Sanz E, Boada J. Adverse drug reactions in paediatric outpatients. Int J Clin Pharmacol Res 1987 7:169 172.
34. Woods CG, Rylance ME, Cullen RE, Rylance GW. Adverse drug reactions in children. BMJ 1987 294:869 870.
35. Cirko-Begovic A, Vrhovac B, Bakran I. Intensive monitoring of adverse drug reactions in infants and preschool children. Eur J Clin Pharmacol 1989 36:63 5.
36. Menniti-Ippolito F, Raschetti R, da Cas R. Active monitoring of adverse drug reactions in children. Lancet 2000 355:1613 1614.
37. Lewis MA, Kühl-Habich D, von Rosen J. Drug use and adverse event monitoring in German children. Int J Clin Pharmacol Ther 2001 39:507 512.
38. Horen B, Montastruc J-L, Lapeyre-Mestre M. Adverse drug reactions and off-label drug use in paediatric outpatients. Br J Clin Pharmacol 2002 54:665 670.
39. Meyboom RH. Adverse reactions to drugs in children, experiences with 'spontaneous monitoring' in the Netherlands. Bratisl Lek Listy 1991 92:554 559.
40. Morales-Olivas FJ, Martinez-Mir I, Ferrer JM, Rubio E, Palop V. Adverse drug reactions in children reported by means of the yellow card in Spain. J Clin Epidemiol 2000 53:1076 1080.
41. Moore TJ, Weiss SR, Kaplan S, Blaisdell CJ. Reported adverse drug events in infants and children under 2 years of age. Pediatrics 2002 110:e53.
42. Schirm E, Tobi H, van Puijenbroek EP, Monster-Simons MH, Jong-van den Berg LTW. Reported adverse drug reactions and their determinants in Dutch children outside the hospital. Pharm Drug Saf 2004 13:159 165.
43. Ufer M, Kimland E, Bergman U. Adverse drug reactions and off-label prescribing for paediatric outpatients: a one-year survey of spontaneous reports in Sweden. Pharm Drug Saf 2004 13:147 152.
44. Kimland E, Rane A, Ufer M, Panagiotidis G. Paediatric adverse drug reactions reported in Sweden from 1987 to 2001. Pharm Drug Saf 2005 14:493 499.
45. Carleton BC, Smith MA, Gelin MN, Heathcote SC. Paediatric adverse drug reaction reporting: understanding and future directions. Can J Clin Pharmacol 2007 14:e45 57.
46. Aagaard L, Weber CB, Hansen EH. Adverse drug reactions in the paediatric population in dDenmark: a retrospective analysis of reports made to the Danish Medicines Agency from 1998 to 2007. Drug Saf 2010 33:327 339.
47. Williams SD, Ashcroft DM. Medication errors: how reliable are the severity ratings reported to the national reporting and learning system? Int J Qual Health Care 2009 21:316 320.
48. Aagaard L, Hansen EH. Information about ADRs explored by pharmacovigilance approaches: a qualitative review of studies on antibiotics, SSRIs and NSAIDs. BMC Clin Pharmacol 2009 9:4.
49. Herdeiro MT, Figueiras A, Polónia J, Gestal-Otero JJ. Physicians' attitudes and adverse drug reaction reporting: a case-control study in Portugal. Drug Saf 2005 28:825 833.
50. Blenkinsopp A, Wilkie P, Wang M, Routledge PA. Patient reporting of suspected adverse drug reactions: a review of published literature and international experience. Br J Clin Pharmacol 2007 63:148 156.